Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Cochlear ( (AU:COH) ) is now available.
Cochlear Limited has issued 6,196 new fully paid ordinary shares on 31 March 2026 following the exercise or conversion of previously unquoted equity securities. The modest share issuance reflects ongoing participation in the company’s equity-based arrangements and results in minor dilution while slightly increasing the company’s capital base and aligning stakeholders through expanded share ownership.
This latest issuance suggests continued utilisation of incentive or convertible structures to reward or retain key personnel or investors, a common practice in the medical device and broader healthcare sector. The small scale of the transaction implies limited immediate impact on overall ownership structure, but it incrementally broadens the shareholder base and may support long-term alignment between management and investors.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$172.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a medical device company that develops and manufactures implantable hearing solutions, including cochlear implants, primarily serving patients with moderate to profound hearing loss. Listed on the ASX under the code COH, the company targets global healthcare markets through partnerships with clinicians and hearing specialists.
YTD Price Performance: -33.04%
Average Trading Volume: 221,424
Technical Sentiment Signal: Sell
Current Market Cap: A$11.27B
See more data about COH stock on TipRanks’ Stock Analysis page.